The Impact of Socioeconomic Status on the Clinical Outcomes of COVID-19; a Retrospective Cohort Study.


Journal

Journal of community health
ISSN: 1573-3610
Titre abrégé: J Community Health
Pays: Netherlands
ID NLM: 7600747

Informations de publication

Date de publication:
08 2021
Historique:
accepted: 29 10 2020
pubmed: 3 1 2021
medline: 5 10 2021
entrez: 2 1 2021
Statut: ppublish

Résumé

There have been limited data assessing the influence of disadvantaged socioeconomic status (SES) on the incidence and clinical outcomes of COVID-19 patients within the diverse communities of the United States. Here, we aim to investigate the association between poverty level, as an indicator of SES, and COVID-19 related clinical outcomes including hospitalization and all-cause mortality. This retrospective cohort study included 3528 patients with laboratory confirmed COVID-19 seen at a large New York City health system between March 1, 2020 and April 1, 2020. Data for neighborhood level poverty was acquired from the American Community Survey 2014-2018 and defined as the percent of residents in each ZIP code whose household income was below the federal poverty threshold (FPT): 0% to < 20% below FPT (low poverty) and > 20% below FPT (high poverty). COVID-19 positive patients who resided in high poverty areas were significantly younger, had a higher prevalence of comorbidities and were more likely to be of female gender or a racial minority when compared to individuals living in low poverty areas. Residence in a high poverty area was not associated with an increased risk of COVID-19 related hospitalization and was found to be associated with a decreased risk of in-hospital mortality. This study suggests the existence of an unequal socioeconomic gradient in the demographic and clinical presentation of COVID-19 patients including differences in age, gender and race between poverty groups. Further studies are needed to fully assess the intersectionality of SES with the COVID-19 pandemic.

Identifiants

pubmed: 33387149
doi: 10.1007/s10900-020-00944-3
pii: 10.1007/s10900-020-00944-3
pmc: PMC7775835
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

794-802

Informations de copyright

© 2021. Springer Science+Business Media, LLC, part of Springer Nature.

Références

N Engl J Med. 2020 Jun 25;382(26):2534-2543
pubmed: 32459916
Ann Epidemiol. 2020 Jul;47:37-44
pubmed: 32419766
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Travel Med Infect Dis. 2020 Mar - Apr;34:101623
pubmed: 32179124
Ann N Y Acad Sci. 2010 Feb;1186:174-89
pubmed: 20201873
Nature. 2020 Aug;584(7821):430-436
pubmed: 32640463
Am J Epidemiol. 1998 Sep 1;148(5):475-86
pubmed: 9737560
J Epidemiol Community Health. 2003 Mar;57(3):186-99
pubmed: 12594195
Soc Sci Med. 2001 Jul;53(1):29-40
pubmed: 11380160
BMC Infect Dis. 2017 Aug 25;17(1):589
pubmed: 28841914
PLoS Med. 2020 Sep 22;17(9):e1003379
pubmed: 32960880
Respir Med. 2003 Nov;97(11):1219-24
pubmed: 14635977
Health Serv Res. 2015 Apr;50(2):398-417
pubmed: 25219917
JAMA. 2020 Apr 28;323(16):1574-1581
pubmed: 32250385
J Epidemiol Community Health. 2020 Aug;74(8):620-623
pubmed: 32385126
Public Health. 2020 Aug;185:266-269
pubmed: 32707468
Int J Public Health. 2012 Aug;57(4):745-50
pubmed: 22297400
J Med Virol. 2021 Feb;93(2):907-915
pubmed: 32706392

Auteurs

Christine Little (C)

Department of Medical Education, Icahn School of Medicine at Mount Sinai, New York, USA.

Mathilda Alsen (M)

Department of Otolaryngology-Head and Neck Surgery, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA.

Joshua Barlow (J)

Department of Medical Education, Icahn School of Medicine at Mount Sinai, New York, USA.

Leonard Naymagon (L)

Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, USA.

Douglas Tremblay (D)

Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, USA.

Eric Genden (E)

Department of Otolaryngology-Head and Neck Surgery, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA.

Samuel Trosman (S)

Department of Otolaryngology-Head and Neck Surgery, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA.

Laura Iavicoli (L)

Department of Emergency Medicine, Icahn School of Medicine at Mount Sinai, New York, USA.

Maaike van Gerwen (M)

Department of Otolaryngology-Head and Neck Surgery, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10029, USA. maaike.vangerwen@mountsinai.org.
Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, USA. maaike.vangerwen@mountsinai.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH